Account
Dentsu appoints Rahul Sengupta as CCO
MUMBAI: Dentsu India, the full-service communication agency from Dentsu Aegis Network, has brought in Rahul Sengupta as the chief creative officer (CCO).
Armed with more than 23 years on experience in advertising, direction and production, Sengupta has worked on brands such as Bajaj two-wheelers, ICICI Prudential, Titan, Tanishq, Britannia, Kwality Walls, Kissan, Nissan, Sony Max, Standard Chartered Bank and Adidas.
For the record, Sengupta began his career at Mudra in 1993 (first in Bengaluru and then in Mumbai) and then moved on to Lowe Worldwide where he was the executive creative director. He joined TBWA India in 2008 as the national creative director, following which, he set up Nineteen Films in 2013. Sengupta holds a degree in economics from St Xavier’s College in Kolkata and an MBA from the Faculty of Management Studies in New Delhi.
Dentsu India CEO Simi Sabhaney said, “I found all that I was looking for in a creative head for Dentsu India so neatly stacked up in Rahul! He comes with a reputation of creating successful and famous campaigns on brands across different sectors. He has the energy to mentor, create and lead. He will also be a part of the Dentsu Aegis Network India Creative Council.”
About his new role, Sengupta said, “A new agency, a new problem to crack every day, an old and much-loved profession and a city that is home. That’s a good place to be back in.”
As a director, Sengupta’s work includes films for Micromax, Havells, Standard Chartered Bank, Gillette, Horlicks, Dabur, Palliative Care Association of India, Bharat Matrimony, Berger Paints, Myntra, Domino’s, Gionee and YouTube. It is pertinent to note here that in the last two years, Sengupta partnered with a of variety agency teams wherein he went on to win five Cannes Lions, two Effies and several awards at Spikes, Clio and the GoaFest.
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
